Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-025-6 | CAS number: 26038-87-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16 Jun 2017 - 10 Jul 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver microsomal enzymes (S9 homogenate), prepared from male Sprague Dawley rats that had been injected intraperitoneally with Aroclor 1254 (500 mg/kg body weight).
- Test concentrations with justification for top dose:
- Dose-range Finding Test
Selection of an adequate range of doses was based on a dose-range finding test with the strains TA100 and the WP2uvrA, both with and without S9-mix. Eight concentrations, 1.7, 5.4, 17, 52, 164, 512, 1600 and 5000 µg/plate were tested in triplicate.
The highest concentration of the test item used in the subsequent mutation assays was 5000 μg/plate. At least five different doses (increasing with approximately half-log steps) of the test item were tested in triplicate in each strain in the absence and presence of S9-mix. - Vehicle / solvent:
- The vehicle of the test item was Milli-Q water (Millipore Corp., Bedford, MA., USA).
- Untreated negative controls:
- yes
- Remarks:
- Milli-Q water
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 2-nitrofluorene
- sodium azide
- methylmethanesulfonate
- other: ICR-191 (Sigma), 2-aminoanthracene (2AA)
- Details on test system and experimental conditions:
- Salmonella typhimurium bacteria and Escherichia coli bacteria
- Rationale for test conditions:
- Recommended test system in international guidelines (e.g. OECD, EC).
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- Based on the results of a GLP OECD 471 study it is concluded that MEA Polyborate 1:1 is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010-05-12 to 2010-07-28
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- Only 64 metaphase spreads examined
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Target gene:
- No data
- Species / strain / cell type:
- lymphocytes:
- Details on mammalian cell type (if applicable):
- No data
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver microsomal enzymes were routinely prepared from adult male Wister rats (6), which wre obtained from Charles Reiver (Sulzfeld, Germany)
- Test concentrations with justification for top dose:
- First cytogenic assay
Without S9-mix: 1000, 3330, 4000 and 5000 µg/ml culture medium ( 3h exposure time, 24 h fixation time)
With S9-mix : 1000, 3330 and 5000 µg/ml culture medium ( 3h exposure time, 24 h fixation time)
Second cytogenic assay
Without S9-mix: 50, 100, 200, 300, 500, 750 and 1000 µg/ml culture medium (24 h and 48 h exposure time, 24 h and 48 h fixation time).
With S9-mix: 1000, 3330 and 5000 µg/ml culture medium (3 h exposure time, 48 h fixation time).
Third cytogenic assay
Without and with S9-mix: 5000 µg/ml culture medium (3 h exposure time, 24 h fixation time). - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: [RPMI 1640 medium]
- Justification for choice of solvent/vehicle:none given - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Preincubation period:
- Exposure duration:3 hour
- Expression time (cells in growth medium):
- Selection time (if incubation with a selection agent):
- Fixation time (start of exposure up to fixation or harvest of cells): 24 hour
SELECTION AGENT (mutation assays):
SPINDLE INHIBITOR (cytogenetic assays):colchcine (0.5
STAIN (for cytogenetic assays):5% (v/v) Glemsa (Merck) solution in tap water
NUMBER OF REPLICATIONS:2
NUMBER OF CELLS EVALUATED:
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS:
- Determination of polyploidy:carried out
- Determination of endoreplication:carried out
- Other:
OTHER: - Evaluation criteria:
- A substance was considered positive (clastogenic) in the chromosome aberration test if:
a) It induced a dose-related statistically significant (Chi-square test, one sided , p<0.05) increase in the number of cells with chromosome aberrations.
b) A statistically significant and biologically relevant increase in the frequencies of the number of cells with chromosome aberrations was observed in the absence of a clear dose-response relationship. - Statistics:
- The parameter used was the increase in the number of cells with chromosome aberrations. The statisitcal significance was given by Chi-square test, one sided , p<0.05.
- Species / strain:
- lymphocytes: human
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: Clastogenicity was observed in the first cytogentic assay. This was assumed to be due to the high pH in that assay. - Remarks on result:
- other: strain/cell type: human lymphocytes
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Based on the results of this study, it is concluded that MEA Polyborate 1:1 has shown a clastogenic response in the chromosome aberration study in experiments where the pH of the treated cultures was above the pH of the solvent control. The clastogenicity was only observed in the first cytogenetic assay. Due to fact that the adjustment of the pH of the cultures treated with MEA Polyborate 1:1 did not show a clastogenic response in the third cytogenetic assay, it has to be assumed that the high pH is responsible for the detected clastogenic activity.
- Executive summary:
Evaluation of the ability of MEA Polyborate 1:1 to induce chromosome aberrations in cultured peripheral human lymphocytes (with repeat experiments). This report describes the effect of MEA Polyborate 1:1 on the number of chromosome aberrations in cultured peripheral human lymphocytes in the presence and absence of a metabolic activation system (phenobarbital and ß-naphthoflavone induced rat liver S9-mix). The possible clastogenicity of MEA Polyborate 1:1 was tested in three independent experiments. The study procedures described in this report were based on the most recent OECD and EC guidelines. Batch EU-SMG 01695 of MEA Polyborate 1:1 was a clear colourless liquid. MEA Polyborate 1:1 was dissolved in RPMI 1640 medium. In the first cytogenetic assay, MEA Polyborate 1:1 was tested up to 5000 µg/ml for a 3 h exposure time with a 24 h fixation time in the absence and presence of 1.8% (v/v) S9-fraction. This is the highest concentration that should be tested according to the guidelines. In the second cytogenetic assay, MEA Polyborate 1:1 was tested up to 1000 µg/ml for a 24 h and 48 h continuous exposure time with a 24 h and 48 h fixation time in the absence of S9-mix. Appropriate toxicity was reached at this dose level. In the presence of S9-mix MEA Polyborate 1:1 was tested up to 5000 µg/ml for a 3 h exposure time with a 48 h fixation time. In the third cytogenetic assay, MEA Polyborate 1:1 was tested at the concentration of 5000 µg/ml for a 3 h exposure time with a 24 h fixation time in the absence and presence of 1.8% (v/v) S9-fraction. In this cytogenetic assay the pH of the cultures which were treated with MEA Polyborate 1:1 was adjusted to the pH of the solvent control. The number of cells with chromosome aberrations found in the solvent control cultures was within the laboratory historical control data range. Positive control chemicals, mitomycin C and cyclophosphamide, both produced a statistically significant increase in the incidence of cells with chromosome aberrations, indicating that the test conditions were adequate and that the metabolic activation system (S9-mix) functioned properly. No biologically relevant effects of MEA Polyborate 1:1 on the number of polyploid cells and cells with endoreduplicated chromosomes were observed both in the absence and presence of S9-mix. Therefore it can be concluded that MEA Polyborate 1:1 does not disturb mitotic processes and cell cycle progression and does not induce numerical chromosome aberrations under the experimental conditions described in this report. In the first and second cytogenetic assay MEA Polyborate 1:1 did not induce a statistically significant or biologically relevant increase in the number of cells with chromosome aberrations in the absence of S9-mix. However exchange figures were observed at all concentrations tested in the first cytogenetic assay. It should be noted that chromosomal exchanges are comparatively rare spontaneous events and therefore greater significance should be attached to the observation of exchange figures. In the first cytogenetic assay, in the presence of S9-mix, MEA Polyborate 1:1 induced a statistically significant, increase in the number of cells with chromosome aberrations at the highest tested concentration of 5000 µg/ml, both when gaps were included and excluded. In the second cytogenetic assay, in the presence of S9-mix, MEA Polyborate 1:1 did not induce a statistically significant or biologically relevant increase in the number of cells with chromosome aberrations. The statistically significant increase in the number of cells with chromosome aberrations and the exchange figures were observed in cultures treated with MEA Polyborate 1:1 which had a pH (8.42 - 9.14) above the negative control (pH = 8.01). It is known that changes in pH induce significant increases in chromosome aberrations. Therefore an additional third cytogenetic assay was performed in which the pH of the cultures treated with MEA Polyborate 1:1 was adjusted to the pH of the solvent control. In the third cytogenetic assay, MEA Polyborate 1:1 did not induce a statistically significant or biologically relevant increase in the number of cells with chromosome aberrations in the absence and presence of S9-mix. Moreover, no exchange figures were observed. Based on the results of this study, it is concluded that MEA Polyborate 1:1 has shown a clastogenic response in the chromosome aberration study in experiments where the pH of the treated cultures was above the pH of the solvent control. The clastogenicity was only observed in the first cytogenetic assay. Due to fact that the adjustment of the pH of the cultures treated with MEA Polyborate 1:1 did not show a clastogenic response in the third cytogenetic assay, it has to be assumed that the high pH is responsible for the detected clastogenic activity.
Referenceopen allclose all
Dose-Range Finding Test: Mutagenic Response of MEA Polyborate 1:1 in the Salmonella typhimurium Reverse Mutation Assay and in the Escherichia coli Reverse Mutation Assay
Direct plate assay
(µg/plate) |
|
||
|
|
|
|
Without S9-mix
Positive control |
722 |
± |
32 |
|
1272 |
± |
76 |
|
Solvent control |
101 |
± |
7 |
|
19 |
± |
6 |
|
1.7 |
99 |
± |
7 |
|
19 |
± |
1 |
|
5.4 |
108 |
± |
5 |
|
18 |
± |
3 |
|
17 |
101 |
± |
25 |
|
25 |
± |
6 |
|
52 |
117 |
± |
9 |
|
23 |
± |
0 |
|
164 |
111 |
± |
29 |
|
21 |
± |
5 |
|
512 |
100 |
± |
16 |
|
22 |
± |
8 |
|
1600 |
110 |
± |
6 |
|
20 |
± |
5 |
|
5000 |
128 |
± |
11 |
n NP |
19 |
± |
6 |
n NP |
With S9-mix
Positive control |
475 |
± |
106 |
|
420 |
± |
13 |
|
Solvent control |
92 |
± |
6 |
|
29 |
± |
10 |
|
1.7 |
107 |
± |
15 |
|
27 |
± |
4 |
|
5.4 |
95 |
± |
12 |
|
25 |
± |
4 |
|
17 |
110 |
± |
12 |
|
28 |
± |
8 |
|
52 |
111 |
± |
16 |
|
29 |
± |
11 |
|
164 |
112 |
± |
14 |
|
24 |
± |
5 |
|
512 |
107 |
± |
9 |
|
27 |
± |
6 |
|
1600 |
101 |
± |
11 |
|
27 |
± |
2 |
|
5000 |
126 |
± |
17 |
n NP |
38 |
± |
4 |
n NP |
NP |
No precipitate |
n |
Normal bacterial background lawn |
Experiment 1: Mutagenic Response of MEA Polyborate 1:1 in the Salmonella typhimurium Reverse Mutation Assay
Direct plate assay
Dose (µg/plate) |
|
||
|
|
|
|
Without S9-mix
Positive control |
790 |
± |
47 |
|
985 |
± |
99 |
|
1193 |
± |
86 |
|
Solvent control |
11 |
± |
2 |
|
6 |
± |
2 |
|
16 |
± |
3 |
|
52 |
16 |
± |
3 |
|
6 |
± |
2 |
|
11 |
± |
6 |
|
164 |
11 |
± |
4 |
|
4 |
± |
1 |
|
15 |
± |
5 |
|
512 |
11 |
± |
7 |
|
6 |
± |
2 |
|
25 |
± |
5 |
|
1600 |
11 |
± |
4 |
|
6 |
± |
2 |
|
16 |
± |
9 |
|
5000 |
6 |
± |
4 |
n NP |
4 |
± |
1 |
n NP |
16 |
± |
2 |
n NP |
|
|
|
|
|
|
|
|
|
|
|
|
|
With S9-mix
Positive control |
328 |
± |
21 |
|
546 |
± |
104 |
|
1022 |
± |
61 |
|
Milli-Q water |
10 |
± |
3 |
|
8 |
± |
4 |
|
24 |
± |
11 |
|
52 |
13 |
± |
2 |
|
7 |
± |
2 |
|
29 |
± |
5 |
|
164 |
10 |
± |
2 |
|
6 |
± |
3 |
|
25 |
± |
9 |
|
512 |
12 |
± |
1 |
|
7 |
± |
3 |
|
30 |
± |
6 |
|
1600 |
13 |
± |
3 |
|
5 |
± |
0 |
|
24 |
± |
3 |
|
5000 |
7 |
± |
2 |
n NP |
8 |
± |
4 |
n NP |
21 |
± |
2 |
n NP |
|
|
|
|
|
|
|
|
|
|
|
|
|
NP |
No precipitate |
n |
Normal bacterial background lawn |
Experiment 2: Mutagenic Response of MEA Polyborate 1:1 in theSalmonella typhimuriumReverse Mutation Assay and in the Escherichia coli Reverse Mutation Assay
Pre-incubation assay
(µg/plate) |
|
||||
|
TA1535 |
|
|
|
|
Without S9-mix
Positive control |
886 |
± |
21 |
|
1183 |
± |
75 |
|
1211 |
± |
169 |
|
708 |
± |
171 |
|
202 |
± |
35 |
|
|
Solvent control |
7 |
± |
2 |
|
9 |
± |
1 |
|
20 |
± |
5 |
|
118 |
± |
4 |
|
36 |
± |
9 |
|
|
52 |
13 |
± |
1 |
|
8 |
± |
2 |
|
34 |
± |
21 |
|
114 |
± |
13 |
|
25 |
± |
10 |
|
|
164 |
12 |
± |
2 |
|
8 |
± |
4 |
|
19 |
± |
7 |
|
104 |
± |
51 |
|
29 |
± |
4 |
|
|
512 |
15 |
± |
5 |
|
8 |
± |
3 |
|
18 |
± |
4 |
|
112 |
± |
20 |
|
31 |
± |
4 |
i |
|
1600 |
9 |
± |
6 |
|
11 |
± |
6 |
|
12 |
± |
4 |
|
149 |
± |
8 |
|
31 |
± |
13 |
|
|
5000 |
9 |
± |
3 |
n SP |
5 |
± |
2 |
n SP |
15 |
± |
5 |
n SP |
179 |
± |
17 |
n SP |
38 |
± |
17 |
n SP |
With S9-mix
Positive control |
217 |
± |
3 |
|
177 |
± |
16 |
|
495 |
± |
86 |
|
1008 |
± |
343 |
|
541 |
± |
13 |
|
Milli-Q water |
19 |
± |
5 |
|
4 |
± |
0 |
|
26 |
± |
2 |
|
118 |
± |
21 |
|
42 |
± |
9 |
|
52 |
8 |
± |
1 |
|
8 |
± |
2 |
|
28 |
± |
13 |
|
116 |
± |
10 |
|
41 |
± |
6 |
|
164 |
11 |
± |
4 |
|
6 |
± |
5 |
|
28 |
± |
2 |
|
135 |
± |
27 |
|
61 |
± |
7 |
|
512 |
10 |
± |
2 |
|
8 |
± |
4 |
|
25 |
± |
7 |
|
145 |
± |
27 |
|
54 |
± |
9 |
|
1600 |
13 |
± |
1 |
|
10 |
± |
8 |
|
23 |
± |
9 |
|
148 |
± |
11 |
|
48 |
± |
9 |
|
5000 |
7 |
± |
2 |
n SP |
5 |
± |
3 |
n SP |
21 |
± |
4 |
n SP |
189 |
± |
18 |
n SP |
52 |
± |
5 |
n SP |
SP |
Slight Precipitate |
i |
Plate infected |
n |
Normal bacterial background lawn |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Based on the results of a GLP OECD 471 study it is concluded that MEA Polyborate 1:1 is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay.
Based on the results of this study, it is concluded that MEA Polyborate 1:1 has shown a clastogenic response in the chromosome aberration study in experiments where the pH of the treated cultures was above the pH of the solvent control. The clastogenicity was only observed in the first cytogenetic assay. Due to fact that the adjustment of the pH of the cultures treated with MEA Polyborate 1:1 did not show a clastogenic response in the third cytogenetic assay, it has to be assumed that the high pH is responsible for the detected clastogenic activity.
The substance is therefore not classified as mutagenic under GHS.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.